Literature DB >> 8395976

A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis.

T Fujiwara1, E A Grimm, T Mukhopadhyay, D W Cai, L B Owen-Schaub, J A Roth.   

Abstract

Multicellular tumor spheroids approximate the three-dimensional configuration of primary and metastatic tumors. The effects of retrovirus-mediated transduction of wild-type p53 (wt-p53) were studied on multicellular tumor spheroids of human non-small cell lung cancer cell lines H322a, the p53 gene of which is homozygously mutated at codon 248, and WT226b, which has endogenous wt-p53. The growth of WT226b spheroids was not affected by exogenous wt-p53 transduction; the growth of H322a spheroids, however, was significantly inhibited by the addition of wt-p53 virus stocks. Transduction of cells by the wt-p53 retroviral vector and penetration of multiple cell layers in H322a spheroids was demonstrated by in situ polymerase chain reaction/hybridization with the neomycin-resistant neo probe. Apoptotic changes indicating programmed cell death were observed in H322a spheroids treated with the wt-p53 virus. These results suggest that retroviral vectors can penetrate into multiple cell layers of three-dimensional tumor masses and induce potentially therapeutic effects.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395976

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  18 in total

Review 1.  Anti-tumor gene therapy.

Authors:  C Cirielli; M C Capogrossi; A Passaniti
Journal:  J Neurooncol       Date:  1997-01       Impact factor: 4.130

Review 2.  Retroviral vectors. From laboratory tools to molecular medicine.

Authors:  R G Vile; A Tuszynski; S Castleden
Journal:  Mol Biotechnol       Date:  1996-04       Impact factor: 2.695

3.  Anti-apoptotic activity of low levels of wild-type p53.

Authors:  P Lassus; M Ferlin; J Piette; U Hibner
Journal:  EMBO J       Date:  1996-09-02       Impact factor: 11.598

Review 4.  Gene Therapy for Lung Cancer.

Authors:  Humberto Lara-Guerra; Jack A Roth
Journal:  Crit Rev Oncog       Date:  2016

5.  Wild-type p53 gene-induced morphological changes and growth suppression in hepatoma cells.

Authors:  S Terai; T Noma; T Kimura; A Nakazawa; F Kurokawa; K Okita
Journal:  J Gastroenterol       Date:  1997-06       Impact factor: 7.527

6.  p53: a gene for all tumours?

Authors:  R G Vile
Journal:  BMJ       Date:  1993-11-13

Review 7.  Antisense oncogene and tumor suppressor gene therapy of cancer.

Authors:  W W Zhang
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

Review 8.  The control of hematopoiesis and leukemia: from basic biology to the clinic.

Authors:  L Sachs
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-14       Impact factor: 11.205

Review 9.  Reflections on viruses and cancer.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

Review 10.  [The use of p53 as a tool for human cancer therapy].

Authors:  V P Almazov; D V Kochetkov; P M Chumakov
Journal:  Mol Biol (Mosk)       Date:  2007 Nov-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.